Skip to main content

GLP-1 Agonists Weight Management

Meaning

GLP-1 Agonists Weight Management refers to the clinical use of Glucagon-Like Peptide-1 Receptor Agonists, a class of pharmaceutical agents, to promote significant and sustained reduction in body mass, particularly in individuals with obesity or type 2 diabetes. These agents mimic the action of the endogenous incretin hormone GLP-1, a gut peptide released in response to nutrient intake. Their efficacy in weight management stems from a dual action: enhancing glucose-dependent insulin secretion and modulating central appetite regulation. This therapeutic strategy is a significant advancement in treating metabolic dysregulation and its hormonal consequences.